2021
DOI: 10.1002/hep.31603
|View full text |Cite
|
Sign up to set email alerts
|

Application of Artificial Intelligence for the Diagnosis and Treatment of Liver Diseases

Abstract: Modern medical care produces large volumes of multimodal patient data, which many clinicians struggle to process and synthesize into actionable knowledge. In recent years, artificial intelligence (AI) has emerged as an effective tool in this regard. The field of hepatology is no exception, with a growing number of studies published that apply AI techniques to the diagnosis and treatment of liver diseases. These have included machine‐learning algorithms (such as regression models, Bayesian networks, and support… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
121
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 127 publications
(121 citation statements)
references
References 90 publications
0
121
0
Order By: Relevance
“…Also, in the future, the use of high-throughput omics (i.e., lipidomics proteomics, metabolomics, and glycomics) investigations will help to generate comprehensive biochemical snapshots allowing one to discriminate between patient subgroups [185,186]. Also, artificial intelligence tools to integrate and analyze big data as well as to develop algorithms combining the information through machine learning strategies [187][188][189] may be of help to better stratifying patients and defining tailored treatment strategies. A more accurate phenotyping of patients may also allow for grouping into more homogenous categories in clinical trials leading to more granular data on the efficacy of drugs in well-defined patient subgroups [26,190].…”
Section: Discussionmentioning
confidence: 99%
“…Also, in the future, the use of high-throughput omics (i.e., lipidomics proteomics, metabolomics, and glycomics) investigations will help to generate comprehensive biochemical snapshots allowing one to discriminate between patient subgroups [185,186]. Also, artificial intelligence tools to integrate and analyze big data as well as to develop algorithms combining the information through machine learning strategies [187][188][189] may be of help to better stratifying patients and defining tailored treatment strategies. A more accurate phenotyping of patients may also allow for grouping into more homogenous categories in clinical trials leading to more granular data on the efficacy of drugs in well-defined patient subgroups [26,190].…”
Section: Discussionmentioning
confidence: 99%
“…In hepatology, artificial intelligence is being used to develop prognostic models, chart review tools using natural language processing, and deep learning-based software for interpretation of crosssectional imaging and histopathological images. 3 In ophthalmology, there have been successful applications of deep learning algorithms for diagnosis of ocular conditions such as glaucoma, diabetic retinopathy, and macular degeneration. 4 Nevertheless, this is the first study to propose an entirely new role for ophthalmological imaging to serve as a screening tool for early detection of hepatobiliary disorders.…”
Section: Deep Learning-based Detection Of Hepatobiliary Disorders In mentioning
confidence: 99%
“…ML is divided into supervised and unsupervised methods. Supervised learning deals with annotated data with input–output pairs and common techniques including linear regression, logistic regression, decision trees, k‐nearest neighbor, support vector machine (SVM), random forest (RF), naive Bayes classification, and gradient boosting 7 . Whereas unsupervised learning occurs when the task is to explore the groups without a priori knowledge within the data.…”
Section: Introductionmentioning
confidence: 99%
“…Whereas unsupervised learning occurs when the task is to explore the groups without a priori knowledge within the data. The k‐means clustering and principal component analysis are within this category 7 . In contrast to the traditional hypothesis‐driven statistical models, ML may use a hypothesis‐free approach to perform unsupervised classification of clinical phenotypes.…”
Section: Introductionmentioning
confidence: 99%